The DOI matches its Crossref record; 124 of the 124 references it cites were found in a registry or an index.
Covid-19 and autoimmunity
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884
Clinical characteristics of coronavirus disease 2019 in China
Guan, W.-J., Ni, Z.-Y., Hu, Y., Liang, W.-H., Ou, C.-Q., He, J.-X., Liu, L., Shan, H., Lei, C.-L., Hui, D. S. C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2002032 · Cited by 30,246
Zhou, F., Yu, T., Du, R., Fan, G., Liu, Y., Liu, Z., Xiang, J., Wang, Y., Song, B., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30566-3 · Cited by 27,263
Wu, Z., & McGoogan, J. M. (2020) · JAMA · doi:10.1001/jama.2020.2648 · Cited by 17,016
MIYAKIS, S., LOCKSHIN, M. D., ATSUMI, T., BRANCH, D. W., BREY, R. L., CERVERA, R., DERKSEN, R. H. W. M., DE GROOT, P. G., KOIKE, T., MERONI, P. L., et al. (2006) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2006.01753.x · Cited by 7,203
Self-citationWang, M., Cao, R., Zhang, L., Yang, X., Liu, J., Xu, M., Shi, Z., Hu, Z., Zhong, W., & Xiao, G. (2020) · Cell Research · doi:10.1038/s41422-020-0282-0 · Cited by 6,958
Ai, T., Yang, Z., Hou, H., Zhan, C., Chen, C., Lv, W., Tao, Q., Sun, Z., & Xia, L. (2020) · Radiology · doi:10.1148/radiol.2020200642 · Cited by 5,685
McCrindle, B. W., Rowley, A. H., Newburger, J. W., Burns, J. C., Bolger, A. F., Gewitz, M., Baker, A. L., Jackson, M. A., Takahashi, M., Shah, P. B., et al. (2017) · Circulation · doi:10.1161/cir.0000000000000484 · Cited by 3,723
CRICS TRIGGERSEP Group (Clinical Research in Intensive Care and Sepsis Trial Group for Global Evaluation and Research in Sepsis), Helms, J., Tacquard, C., Severac, F., Leonard-Lorant, I., Ohana, M., Delabranche, X., Merdji, H., Clere-Jehl, R., Schenck, M., et al. (2020) · Intensive Care Medicine · doi:10.1007/s00134-020-06062-x · Cited by 2,792
Effective treatment of severe COVID-19 patients with tocilizumab
Xu, X., Han, M., Li, T., Sun, W., Wang, D., Fu, B., Zhou, Y., Zheng, X., Yang, Y., Li, X., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2005615117 · Cited by 2,647
Hyperinflammatory shock in children during COVID-19 pandemic
Riphagen, S., Gomez, X., Gonzalez-Martinez, C., Wilkinson, N., & Theocharis, P. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31094-1 · Cited by 2,494
Verdoni, L., Mazza, A., Gervasoni, A., Martelli, L., Ruggeri, M., Ciuffreda, M., Bonanomi, E., & D'Antiga, L. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31103-x · Cited by 2,380
Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19
Zhang, Y., Xiao, M., Zhang, S., Xia, P., Cao, W., Jiang, W., Chen, H., Ding, X., Zhao, H., Zhang, H., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2007575 · Cited by 2,179
Large-Vessel Stroke as a Presenting Feature of Covid-19 in the Young
Oxley, T. J., Mocco, J., Majidi, S., Kellner, C. P., Shoirah, H., Singh, I. P., De Leacy, R. A., Shigematsu, T., Ladner, T. R., Yaeger, K. A., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2009787 · Cited by 2,116
Liu, J., Cao, R., Xu, M., Wang, X., Zhang, H., Hu, H., Li, Y., Hu, Z., Zhong, W., & Wang, M. (2020) · Cell Discovery · doi:10.1038/s41421-020-0156-0 · Cited by 2,070
Cytokine release syndrome in severe COVID-19
Moore, J. B., & June, C. H. (2020) · Science · doi:10.1126/science.abb8925 · Cited by 1,912 · cited 1×
“These cases with Covid-19 are those who develop through the excessive cytokine release and the uncontrolled immune activation, the multiorgan failure with a grave prognosis [24,25].”
Chloroquine is a potent inhibitor of SARS coronavirus infection and spread
Vincent, M. J., Bergeron, E., Benjannet, S., Erickson, B. R., Rollin, P. E., Ksiazek, T. G., Seidah, N. G., & Nichol, S. T. (2005) · Virology Journal · doi:10.1186/1743-422x-2-69 · Cited by 1,811
Lippi, G., Plebani, M., & Henry, B. M. (2020) · Clinica Chimica Acta · doi:10.1016/j.cca.2020.03.022 · Cited by 1,706
McGonagle, D., Sharif, K., O'Regan, A., & Bridgewood, C. (2020) · Autoimmunity Reviews · doi:10.1016/j.autrev.2020.102537 · Cited by 1,654
Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19
Geleris, J., Sun, Y., Platt, J., Zucker, J., Baldwin, M., Hripcsak, G., Labella, A., Manson, D. K., Kubin, C., Barr, R. G., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2012410 · Cited by 1,625
Zhong, N., Zheng, B., Li, Y., Poon, L., Xie, Z., Chan, K., Li, P., Tan, S., Chang, Q., Xie, J., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14630-2 · Cited by 1,579
Guillain–Barré Syndrome Associated with SARS-CoV-2
Toscano, G., Palmerini, F., Ravaglia, S., Ruiz, L., Invernizzi, P., Cuzzoni, M. G., Franciotta, D., Baldanti, F., Daturi, R., Postorino, P., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2009191 · Cited by 1,260
Review of the 2019 novel coronavirus (SARS-CoV-2) based on current evidence
Wang, L., Wang, Y., Ye, D., & Liu, Q. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.105948 · Cited by 1,193
Rosenberg, E. S., Dufort, E. M., Udo, T., Wilberschied, L. A., Kumar, J., Tesoriero, J., Weinberg, P., Kirkwood, J., Muse, A., DeHovitz, J., et al. (2020) · JAMA · doi:10.1001/jama.2020.8630 · Cited by 1,156
Li, Y., Li, M., Wang, M., Zhou, Y., Chang, J., Xian, Y., Wang, D., Mao, L., Jin, H., & Hu, B. (2020) · Stroke and Vascular Neurology · doi:10.1136/svn-2020-000431 · Cited by 1,066
Clinical Features of 69 Cases With Coronavirus Disease 2019 in Wuhan, China
Wang, Z., Yang, B., Li, Q., Wen, L., & Zhang, R. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa272 · Cited by 1,063
Guillain-Barré syndrome associated with SARS-CoV-2 infection: causality or coincidence?
Zhao, H., Shen, D., Zhou, H., Liu, J., & Chen, S. (2020) · The Lancet Neurology · doi:10.1016/s1474-4422(20)30109-5 · Cited by 993
Cavalli, G., De Luca, G., Campochiaro, C., Della-Torre, E., Ripa, M., Canetti, D., Oltolini, C., Castiglioni, B., Tassan Din, C., Boffini, N., et al. (2020) · The Lancet Rheumatology · doi:10.1016/s2665-9913(20)30127-2 · Cited by 970
Miller Fisher syndrome and polyneuritis cranialis in COVID-19
Gutiérrez-Ortiz, C., Méndez-Guerrero, A., Rodrigo-Rey, S., San Pedro-Murillo, E., Bermejo-Guerrero, L., Gordo-Mañas, R., de Aragón-Gómez, F., & Benito-León, J. (2020) · Neurology · doi:10.1212/wnl.0000000000009619 · Cited by 810
Ravelli, A., Minoia, F., Davì, S., Horne, A., Bovis, F., Pistorio, A., Aricò, M., Avcin, T., Behrens, E. M., De Benedetti, F., et al. (2016) · Arthritis & Rheumatology · doi:10.1002/art.39332 · Cited by 773
COVID-19 and Kawasaki Disease: Novel Virus and Novel Case
Jones, V. G., Mills, M., Suarez, D., Hogan, C. A., Yeh, D., Segal, J. B., Nguyen, E. L., Barsh, G. R., Maskatia, S., & Mathew, R. (2020) · Hospital Pediatrics · doi:10.1542/hpeds.2020-0123 · Cited by 766
Toniati, P., Piva, S., Cattalini, M., Garrafa, E., Regola, F., Castelli, F., Franceschini, F., Airò, P., Bazzani, C., Beindorf, E.-A., et al. (2020) · Autoimmunity Reviews · doi:10.1016/j.autrev.2020.102568 · Cited by 751
Self-citationMolecular Mimicry, Bystander Activation, or Viral Persistence: Infections and Autoimmune Disease
Fujinami, R. S., von Herrath, M. G., Christen, U., & Whitton, J. L. (2006) · Clinical Microbiology Reviews · doi:10.1128/cmr.19.1.80-94.2006 · Cited by 679
Jamilloux, Y., Henry, T., Belot, A., Viel, S., Fauter, M., El Jammal, T., Walzer, T., François, B., & Sève, P. (2020) · Autoimmunity Reviews · doi:10.1016/j.autrev.2020.102567 · Cited by 658
On the Alert for Cytokine Storm: Immunopathology in COVID‐19
Henderson, L. A., Canna, S. W., Schulert, G. S., Volpi, S., Lee, P. Y., Kernan, K. F., Caricchio, R., Mahmud, S., Hazen, M. M., Halyabar, O., et al. (2020) · Arthritis & Rheumatology · doi:10.1002/art.41285 · Cited by 633
Guillain Barre syndrome associated with COVID-19 infection: A case report
Sedaghat, Z., & Karimi, N. (2020) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2020.04.062 · Cited by 575
COVID‐19 epidemic: Disease characteristics in children
She, J., Liu, L., & Liu, W. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25807 · Cited by 521
Onouchi, Y., Gunji, T., Burns, J. C., Shimizu, C., Newburger, J. W., Yashiro, M., Nakamura, Y., Yanagawa, H., Wakui, K., Fukushima, Y., et al. (2008) · Nature Genetics · doi:10.1038/ng.2007.59 · Cited by 510
Lupus Anticoagulant and Abnormal Coagulation Tests in Patients with Covid-19
Bowles, L., Platton, S., Yartey, N., Dave, M., Lee, K., Hart, D. P., MacDonald, V., Green, L., Sivapalaratnam, S., Pasi, K. J., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2013656 · Cited by 487
COVID-19 infection and rheumatoid arthritis: Faraway, so close
Favalli, E. G., Ingegnoli, F., De Lucia, O., Cincinelli, G., Cimaz, R., & Caporali, R. (2020) · Autoimmunity Reviews · doi:10.1016/j.autrev.2020.102523 · Cited by 454
Monti, S., Balduzzi, S., Delvino, P., Bellis, E., Quadrelli, V. S., & Montecucco, C. (2020) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2020-217424 · Cited by 446
Antibody-dependent SARS coronavirus infection is mediated by antibodies against spike proteins
Wang, S.-F., Tseng, S.-P., Yen, C.-H., Yang, J.-Y., Tsao, C.-H., Shen, C.-W., Chen, K.-H., Liu, F.-T., Liu, W.-T., Chen, Y.-M. A., et al. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.07.090 · Cited by 421
The role of infections in autoimmune disease
Ercolini, A. M., & Miller, S. D. (2008) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2008.03834.x · Cited by 413
Ravelli, A., Minoia, F., Davì, S., Horne, A., Bovis, F., Pistorio, A., Aricò, M., Avcin, T., Behrens, E. M., De Benedetti, F., et al. (2016) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2015-208982 · Cited by 410
Covid-19 in Immune-Mediated Inflammatory Diseases — Case Series from New York
Haberman, R., Axelrad, J., Chen, A., Castillo, R., Yan, D., Izmirly, P., Neimann, A., Adhikari, S., Hudesman, D., & Scher, J. U. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2009567 · Cited by 405
Epidemiologic Features of Kawasaki Disease in Japan: Results of the 2009–2010 Nationwide Survey
Nakamura, Y., Yashiro, M., Uehara, R., Sadakane, A., Tsuboi, S., Aoyama, Y., Kotani, K., Tsogzolbaatar, E.-O., & Yanagawa, H. (2012) · Journal of Epidemiology · doi:10.2188/jea.je20110126 · Cited by 382
Hospitalizations for Kawasaki Syndrome Among Children in the United States, 1997–2007
Holman, R. C., Belay, E. D., Christensen, K. Y., Folkema, A. M., Steiner, C. A., & Schonberger, L. B. (2010) · Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e3181cf8705 · Cited by 341
Dengue Antibody-Dependent Enhancement: Knowns and Unknowns
Halstead, S. B. (2014) · Microbiology Spectrum · doi:10.1128/microbiolspec.aid-0022-2014 · Cited by 336
Immune Thrombocytopenic Purpura in a Patient with Covid-19
Zulfiqar, A.-A., Lorenzo-Villalba, N., Hassler, P., & Andrès, E. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2010472 · Cited by 319
Caso, F., Costa, L., Ruscitti, P., Navarini, L., PUENTE, A. D., Giacomelli, R., & Scarpa, R. (2020) · Autoimmunity Reviews · doi:10.1016/j.autrev.2020.102524 · Cited by 317
Blank, M., Krause, I., Fridkin, M., Keller, N., Kopolovic, J., Goldberg, I., Tobar, A., & Shoenfeld, Y. (2002) · Journal of Clinical Investigation · doi:10.1172/jci12337 · Cited by 303
Self-citationViral infections and antiphospholipid antibodies
Uthman, I. W., & Gharavi, A. E. (2002) · Seminars in Arthritis and Rheumatism · doi:10.1053/sarh.2002.28303 · Cited by 300
Middle East respiratory syndrome coronavirus (MERS-CoV): A review
Ramadan, N., & Shaib, H. (2019) · Germs · doi:10.18683/germs.2019.1155 · Cited by 297
Clinical and Autoimmune Characteristics of Severe and Critical Cases of COVID‐19
Zhou, Y., Han, T., Chen, J., Hou, C., Hua, L., He, S., Guo, Y., Zhang, S., Wang, Y., Yuan, J., et al. (2020) · Clinical and Translational Science · doi:10.1111/cts.12805 · Cited by 294
Lupus anticoagulant is frequent in patients with Covid‐19
Harzallah, I., Debliquis, A., & Drénou, B. (2020) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.14867 · Cited by 290
Shoenfeld, Y., & Isenberg, D. A. (1989) · Immunology Today · doi:10.1016/0167-5699(89)90245-4 · Cited by 288
Self-citationCOVID-19 gone bad: A new character in the spectrum of the hyperferritinemic syndrome?
Colafrancesco, S., Alessandri, C., Conti, F., & Priori, R. (2020) · Autoimmunity Reviews · doi:10.1016/j.autrev.2020.102573 · Cited by 268
Blank, M., Krause, I., Fridkin, M., Keller, N., Kopolovic, J., Goldberg, I., Tobar, A., & Shoenfeld, Y. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0212337 · Cited by 265
Self-citationA New Serologically Active Phospholipid from Beef Heart
Pangborn, M. C. (1941) · Experimental Biology and Medicine · doi:10.3181/00379727-48-13365p · Cited by 250
Mathian, A., Mahevas, M., Rohmer, J., Roumier, M., Cohen-Aubart, F., Amador-Borrero, B., Barrelet, A., Chauvet, C., Chazal, T., Delahousse, M., et al. (2020) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2020-217566 · Cited by 242
Mikuls, T. R., Johnson, S. R., Fraenkel, L., Arasaratnam, R. J., Baden, L. R., Bermas, B. L., Chatham, W., Cohen, S., Costenbader, K., Gravallese, E. M., et al. (2021) · Arthritis & Rheumatology · doi:10.1002/art.41596 · Cited by 241
Alijotas-Reig, J., Esteve-Valverde, E., Belizna, C., Selva-O'Callaghan, A., Pardos-Gea, J., Quintana, A., Mekinian, A., Anunciacion-Llunell, A., & Miró-Mur, F. (2020) · Autoimmunity Reviews · doi:10.1016/j.autrev.2020.102569 · Cited by 235
Self-citationAouba, A., Baldolli, A., Geffray, L., Verdon, R., Bergot, E., Martin-Silva, N., & Justet, A. (2020) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2020-217706 · Cited by 228
BARZILAI, O., SHERER, Y., RAM, M., IZHAKY, D., ANAYA, J. M., & SHOENFELD, Y. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1422.059 · Cited by 212
Self-citationGianfrancesco, M. A., Hyrich, K. L., Gossec, L., Strangfeld, A., Carmona, L., Mateus, E. F., Sufka, P., Grainger, R., Wallace, Z., Bhana, S., et al. (2020) · The Lancet Rheumatology · doi:10.1016/s2665-9913(20)30095-3 · Cited by 212
Infectious origin of the antiphospholipid syndrome
Shoenfeld, Y., Blank, M., Cervera, R., Font, J., Raschi, E., & Meroni, P.-L. (2006) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2005.045443 · Cited by 206
Self-citationDisrupted Intricacy of Histone H3K4 Methylation in Neurodevelopmental Disorders
Vallianatos, C. N., & Iwase, S. (2015) · Epigenomics · doi:10.2217/epi.15.1 · Cited by 201
Antiphospholipid antibodies, antiphospholipid syndrome and infections
Sène, D., Piette, J.-C., & Cacoub, P. (2008) · Autoimmunity Reviews · doi:10.1016/j.autrev.2007.10.001 · Cited by 190
Mikuls, T. R., Johnson, S. R., Fraenkel, L., Arasaratnam, R. J., Baden, L. R., Bermas, B. L., Chatham, W., Cohen, S., Costenbader, K., Gravallese, E. M., et al. (2020) · Arthritis & Rheumatology · doi:10.1002/art.41301 · Cited by 179
The immune system of children: the key to understanding SARS-CoV-2 susceptibility?
Carsetti, R., Quintarelli, C., Quinti, I., Piano Mortari, E., Zumla, A., Ippolito, G., & Locatelli, F. (2020) · The Lancet Child & Adolescent Health · doi:10.1016/s2352-4642(20)30135-8 · Cited by 176
Selmi, C. F., Leung, P. S. C., Sherr, D. H., Diaz, M., Nyland, J. F., Monestier, M., Rose, N. R., & Gershwin, M. E. (2012) · Journal of Autoimmunity · doi:10.1016/j.jaut.2012.05.007 · Cited by 169
Viral infection can induce the production of autoantibodies
Barzilai, O., Ram, M., & Shoenfeld, Y. (2007) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e3282f0ad25 · Cited by 168
Self-citationSARS-CoV-2 infection among patients with systemic autoimmune diseases
Emmi, G., Bettiol, A., Mattioli, I., Silvestri, E., Scala, G. D., Urban, M. L., Vaglio, A., & Prisco, D. (2020) · Autoimmunity Reviews · doi:10.1016/j.autrev.2020.102575 · Cited by 158
Li, Y., Zheng, Q., Zou, L., et al. (2019) · Pediatric Rheumatology · doi:10.1186/s12969-018-0303-4 · Cited by 155
On the molecular determinants of the SARS-CoV-2 attack
Kanduc, D., & Shoenfeld, Y. (2020) · Clinical Immunology · doi:10.1016/j.clim.2020.108426 · Cited by 144
Self-citationThe autoimmunologist: geoepidemiology, a new center of gravity, and prime time for autoimmunity
Shoenfeld, Y., Selmi, C. F., Zimlichman, E., & Gershwin, M. E. (2008) · Journal of Autoimmunity · doi:10.1016/j.jaut.2008.08.004 · Cited by 142
Self-citationHepatitis B Virus (HBV) and Autoimmune Disease
Maya, R., Gershwin, M. E., & Shoenfeld, Y. (2007) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-007-8013-6 · Cited by 138
Self-citationThe role of viral infections in the development of autoimmune diseases
Hussein, H. M., & Rahal, E. A. (2019) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2019.1614904 · Cited by 131
Guilpain, P., Bihan, C. L., Foulongne, V., Taourel, P., Pansu, N., Maria, A. T. J., Jung, B., Larcher, R., Klouche, K., & Moing, V. L. (2020) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2020-217549 · Cited by 130
Favalli, E. G., Monti, S. M., Ingegnoli, F., Balduzzi, S., Caporali, R. F., & Montecucco, C. (2020) · Arthritis & Rheumatology · doi:10.1002/art.41388 · Cited by 127
Pengo, V., Ruffatti, A., Tonello, M., Cuffaro, S., Banzato, A., Bison, E., Denas, G., & Padayattil Jose, S. (2015) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.12865 · Cited by 126
Environmental Basis of Autoimmunity
Floreani, A., Leung, P. S. C., & Gershwin, M. E. (2016) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-015-8493-8 · Cited by 122 · cited 1×
“drome, primary billiary cholangitis, multiple sclerosis, polymoysitis, uveitis, Henoch Schonlein Puprpura, Systemic Juvenile Idiopathic arthritis, systemic sclerosis, Hashimoto thyroiditis and autoimmune hepatitis [12,13].”
Molecular mimicry may explain multi-organ damage in COVID-19
Angileri, F., Légaré, S., Gammazza, A. M., de Macario, E. C., Macario, A. J. L., & Cappello, F. (2020) · Autoimmunity Reviews · doi:10.1016/j.autrev.2020.102591 · Cited by 119
Guillain–Barré Syndrome—A Classical Autoimmune Disease Triggered by Infection or Vaccination
Israeli, E., Agmon‐Levin, N., Blank, M., Chapman, J., & Shoenfeld, Y. (2010) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-010-8213-3 · Cited by 117
Self-citationAndréoli, L., Chighizola, C. B., Nalli, C., Gerosa, M., Borghi, M. O., Pregnolato, F., Grossi, C., Zanola, A., Allegri, F., Norman, G. L., et al. (2015) · Arthritis & Rheumatology · doi:10.1002/art.39187 · Cited by 113
Self-citationCassione, E. B., Zanframundo, G., Biglia, A., Codullo, V., Montecucco, C., & Cavagna, L. (2020) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2020-217717 · Cited by 106
Gagiannis, D., Steinestel, J., Hackenbroch, C., Schreiner, B., Hannemann, M., Bloch, W., Umathum, V. G., Gebauer, N., Rother, C., Stahl, M., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.587517 · Cited by 103
Describing Kawasaki shock syndrome: results from a retrospective study and literature review
Taddio, A., Rossi, E. D., Monasta, L., Pastore, S., Tommasini, A., Lepore, L., Bronzetti, G., Marrani, E., Mottolese, B. D., Simonini, G., et al. (2016) · Clinical Rheumatology · doi:10.1007/s10067-016-3316-8 · Cited by 91
Are my patients with rheumatic diseases at higher risk of COVID-19?
Figueroa‐Parra, G., Aguirre-García, G. M., Gamboa-Alonso, C. M., Camacho-Ortíz, A., & Galarza-Delgado, D. Á. (2020) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2020-217322 · Cited by 86
Gendelman, O., Amital, H., Bragazzi, N. L., Watad, ., & Chodick, G. (2020) · Autoimmunity Reviews · doi:10.1016/j.autrev.2020.102566 · Cited by 86
Self-citationCytokine storm syndrome in severe COVID-19
Ruscitti, P., Berardicurti, O., Iagnocco, A., & Giacomelli, R. (2020) · Autoimmunity Reviews · doi:10.1016/j.autrev.2020.102562 · Cited by 85
Khamashta, M. A., Taraborelli, M., Sciascia, S., & Tincani, A. (2016) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2016.04.002 · Cited by 81
Self-citationClinical and Molecular Evidence for Association of SLE with parvovirus B19
Pavlović, M. D., Kats, A., Cavallo, M., & Shoenfeld, Y. (2010) · Lupus · doi:10.1177/0961203310365715 · Cited by 80
Self-citationWhat Does the COVID-19 Pandemic Mean for Rheumatology Patients?
Pope, J. E. (2020) · Current Treatment Options in Rheumatology · doi:10.1007/s40674-020-00145-y · Cited by 77
Peptide cross-reactivity the original sin of vaccines
Kanduc, D. (2012) · Frontiers in Bioscience-Scholar · doi:10.2741/s341 · Cited by 75
Self-citationMolecular Mimicry: Its Evolution from Concept to Mechanism as a Cause of Autoimmune Diseases
Oldstone, M. B. A. (2014) · Monoclonal Antibodies in Immunodiagnosis and Immunotherapy · doi:10.1089/mab.2013.0090 · Cited by 73
Hyperferritinemia in autoimmunity.
Zandman‐Goddard, G., & Shoenfeld, Y. (2008) · PubMed · Cited by 69
Self-citationImmune thrombocytopaenic purpura: an autoimmune cross-link between infections and vaccines
Rinaldi, M., Perricone, C., Ortega-Hernandez, O.-D., Perricone, R., & Shoenfeld, Y. (2014) · Lupus · doi:10.1177/0961203313499959 · Cited by 69
Self-citationImmune Thrombocytopenia (ITP) in a Pediatric Patient Positive for SARS-CoV-2
Tsao, H. S., Chason, H. M., & Fearon, D. M. (2020) · PEDIATRICS · doi:10.1542/peds.2020-1419 · Cited by 65
Matucci‐Cerinic, M., Bruni, C., Allanore, Y., Clementi, M., Dagna, L., Damjanov, N. S., de Paulis, A., Denton, C. P., Distler, O., Fox, D. A., et al. (2020) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2020-217407 · Cited by 62
Ponchel, F., Cuthbert, R. J., & Goëb, V. (2010) · Clinica Chimica Acta · doi:10.1016/j.cca.2010.09.002 · Cited by 60
Impact of COVID-19 pandemic on patients with large-vessel vasculitis in Italy: a monocentric survey
Tomelleri, A., Sartorelli, S., Campochiaro, C., Baldissera, E. M., & Dagna, L. (2020) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2020-217600 · Cited by 60
Conticini, E., Bargagli, E., Bardelli, M., Rana, G. D., Baldi, C., Cameli, P., Gentileschi, S., Bennett, D., Falsetti, P., Lanzarone, N., et al. (2020) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2020-217681 · Cited by 57
COVID-19 with rheumatic diseases: a report of 5 cases
Cheng, C., Li, C., Zhao, T., Yue, J., Yang, F., Yan, Y., & Liu, X. (2020) · Clinical Rheumatology · doi:10.1007/s10067-020-05160-x · Cited by 54
Pierangeli, S. S., Blank, M., Liu, X., Espinola, R. G., Fridkin, M., Vega-Ostertag, M. E., Roye-Green, K. J., Harris, E. N., & Shoenfeld, Y. (2004) · Journal of Autoimmunity · doi:10.1016/j.jaut.2004.01.002 · Cited by 53
Self-citationIssues of pathology of a new coronavirus infection CoVID-19
Zinserling, V. A., Vashukova, M. A., Vasilyeva, M., Isakov, A. N., Lugovskaya, N. A., Narkevich, T. A., Sukhanova, Y. V., Semenova, N. Y., & Gusev, D. A. (2020) · Journal Infectology · doi:10.22625/2072-6732-2020-12-2-5-11 · Cited by 52
Self-citationRole of immunosuppressive therapy in rheumatic diseases concurrent with COVID-19
Lu, C., Li, S., & Liu, Y. (2020) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2020-217460 · Cited by 47
The Urgency of Care during the Covid-19 Pandemic — Learning as We Go
Rubin, E. J., Harrington, D. P., Hogan, J. W., Gatsonis, C. A., Baden, L. R., & Hamel, M. B. (2020) · New England Journal of Medicine · doi:10.1056/nejme2015903 · Cited by 47
Infections as a cause of autoimmune rheumatic diseases
Sakkas, L. I., & Bogdanos, D. P. (2016) · Autoimmunity Highlights · doi:10.1007/s13317-016-0086-x · Cited by 46
From HBV to HPV: Designing vaccines for extensive and intensive vaccination campaigns worldwide
Kanduc, D., & Shoenfeld, Y. (2016) · Autoimmunity Reviews · doi:10.1016/j.autrev.2016.07.030 · Cited by 42
Self-citationUnderstanding toxic shock syndrome
Burnham, J. P., & Kollef, M. H. (2015) · Intensive Care Medicine · doi:10.1007/s00134-015-3861-7 · Cited by 41
The Viral-Autoimmunity Relationship
COHEN, A. D., & Shoenfeld, Y. (1995) · Viral Immunology · doi:10.1089/vim.1995.8.1 · Cited by 36
Self-citationReshaping the Mosaic of Autoimmunity
Amital, H., Gershwin, M. E., & Shoenfeld, Y. (2006) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2005.09.002 · Cited by 34
Self-citationWhat is the role of rheumatologists in the era of COVID-19?
Marotto, D., & Sarzi‐Puttini, P. (2020) · Autoimmunity Reviews · doi:10.1016/j.autrev.2020.102539 · Cited by 34
Qaseem, A., Yost, J., Etxeandia‐Ikobaltzeta, I., Miller, M. C., Abraham, G. M., Obley, A. J., Forciea, M. A., Jokela, J. A., & Humphrey, L. L. (2020) · Annals of Internal Medicine · doi:10.7326/m20-1998 · Cited by 32
Catastrophic Antiphospholipid Syndrome
Cervera, R., Bucciarelli, S., Espinosa, G., Gómez-Puerta, J. A., Ramos‐Casals, M., Shoenfeld, Y., Pietté, J. C., & Asherson, R. A. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1422.047 · Cited by 27
Self-citationMathian, A., & Amoura, Z. (2020) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2020-217875 · Cited by 22
Qaseem, A., Yost, J., Etxeandia‐Ikobaltzeta, I., Miller, M. C., Abraham, G. M., Obley, A. J., Forciea, M. A., Jokela, J. A., & Humphrey, L. L. (2020) · Annals of Internal Medicine · doi:10.7326/m20-3862 · Cited by 20
Papa, N. D., Sambataro, G., Minniti, A., Pignataro, F. S., & Caporali, R. F. (2020) · Autoimmunity Reviews · doi:10.1016/j.autrev.2020.102558 · Cited by 19
Why judiciously timed anti-IL 6 therapy may be of benefit in severe COVID-19 infection
Cunningham, L., Kimber, I., Basketter, D. A., & McFadden, J. P. (2020) · Autoimmunity Reviews · doi:10.1016/j.autrev.2020.102563 · Cited by 18
Review: Hepatitis C virus, autoimmunity and rheumatic disease
Buskila, D., Sikuler, E., & Shoenfeld, Y. (1997) · Lupus · doi:10.1177/096120339700600902 · Cited by 14
Self-citationGenetics and Origin of Antiphospholipid Syndrome
Soriano, A., Blank, M., & Shoenfeld, Y. (2014) · Rare diseases of the immune system · doi:10.1007/978-3-319-11044-8_1 · Cited by 6
Self-citationAntiphospholipid Antibodies and Their Relationship With Infections, Vaccines, and Drugs
Torres-Ruiz, J. J., Blank, M., Zandman‐Goddard, G., Sherer, Y., & Shoenfeld, Y. (2016) · Technical report · doi:10.1016/b978-0-444-63655-3.00011-9 · Cited by 4
Self-citationShoenfeld, Y. (2020) · PubMed · Cited by 1
Self-citation
Cited by
Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments
Yong, S. J. (2021) · Infectious Diseases · doi:10.1080/23744235.2021.1924397 · Cited by 1,339
“This is consistent with autopsy examinations of deceased COVID-19 patients showing that infiltrates in the lungs and other organs were enriched with CD8 þ T cells, one of the crucial mediators of autoimmune reactions [105].”
ResultProthrombotic autoantibodies in serum from patients hospitalized with COVID-19
Zuo, Y., Estes, S. K., Ali, R. A., Gandhi, A. A., Yalavarthi, S., Shi, H., Sule, G., Gockman, K., Madison, J. A., Zuo, M., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.abd3876 · Cited by 660
New‐onset autoimmune phenomena post‐COVID‐19 vaccination
Chen, Y., Xu, Z., Wang, P., Li, X., Shuai, Z., Ye, D., & Pan, H. (2022) · Immunology · doi:10.1111/imm.13443 · Cited by 502
The SARS-CoV-2 as an instrumental trigger of autoimmunity
Dotan, A., Muller, S., Kanduc, D., David, P., Halpert, G., & Shoenfeld, Y. (2021) · Autoimmunity Reviews · doi:10.1016/j.autrev.2021.102792 · Cited by 494
Self-citationLong-term complications of COVID-19
Desai, A. D., Lavelle, M., Boursiquot, B. C., & Wan, E. Y. (2022) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00375.2021 · Cited by 415
Metadata
- Authors
- Ehrenfeld, M., Tincani, A., Andreoli, L., Cattalini, M., Greenbaum, A., Kanduc, D., Alijotas-Reig, J., Zinserling, V., Semenova, N., Amital, H., & Shoenfeld, Y.
- Venue
- Autoimmunity Reviews
- Publisher
- Elsevier BV
- Published
- 2020-08
- Volume
- 19
- Issue
- 8
- Pages
- 102597
- ISSN
- 1568-9972 (ISSN-L)
- OpenAlex
- W3035618713
- Cited by
- 559
- References
- 124
- FWCI
- 73.73
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.